Les publications cls sont : Lau et al., Lancet 2021 (PMID 34798060) pour l'essai Phase 2 (n=706), l'essai REDEFINE 1 (NEJM 2025) pour la Phase 3, et Lau et al., J Med Chem 2021 pour le dveloppement molculaire
Carolina Schneider, MS, RD, nutrition advisor at Daily Harvest, says GLP-1 medications work by reducing appetite, so individuals on these medications must prioritize nutrient-dense foods to meet daily nutritional needs despite reduced food intake. Consuming the wrong types of food can not only reduce the effectiveness of the medication, but also exacerbate side effects
Gould RL, Pazdro R
Animal studies suggest oral BPC-157 can protect and heal the gut lining
Transvasin heat rub should be massaged into the affected areas
doi:10.1016/j.redox.2020.101544 56